Highlights
A collection of news and information related to Hospira, Inc. published by this site and its partners.
Displaying items 1-12 of 25
» View wsbt.com items only
1
2
3
•
Next >
-
FDA: New suppliers to ease 2 cancer drug shortages
AP Business WriterTRENTON, N.J. (AP) — Federal regulators said Tuesday that they've approved new suppliers for two crucial cancer drugs, easing critical shortages — at least for the time being — that have left patients and parents frightened about missing...Tags: Chemical Industry, Hospitals and Clinics, Leukemia, Methotrexate (drug), Industrial Production
-
U.S. drug maker discontinues key death penalty drug
COLUMBUS, Ohio (AP) — The sole U.S. manufacturer of a key lethal injection drug says it's discontinuing drug's production because it couldn't guarantee Italian authorities that it wouldn't be used in executions. Hospira Inc., of Lake Forest, Ill.,...Tags: Ohio, Companies and Corporations, Death Penalty, Italy, Lake Forest
-
U.S. court ruling favors Cubist in patent case vs Hospira
ReutersMay 20 (Reuters) - A U.S. federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin by Hospira Inc. The ruling, in U.S. District Court in...Tags: Cubist Pharmaceuticals Incorporated, Stock Market, NASDAQ, Patents, Copyrights and Trademarks, Lake Forest
-
U.S. court ruling favors Cubist in patent case versus Hospira
Reuters(Reuters) - A federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin by Hospira Inc . The ruling, in U.S. District Court in Delaware,...Tags: Cubist Pharmaceuticals Incorporated, Stock Market, NASDAQ, Patents, Copyrights and Trademarks, NYSE Euronext, Inc.
-
FDA again warns Hospira on medical devices
Crain's Chicago Business reports: Hospira has received another warning from the Food and Drug Adminstration regarding the design and quality assurances of its medical devices. This warning reflects FDA dissatisfaction with Hospira's response to an earlier...
Tags: Food and Drug Administration
-
Chief scientific officer back at Hospira after 2 months at competitor
Tribune reporterHospira Inc. has brought back a top executive after just two months at a competitor, the company announced Tuesday. Dr. Sumant Ramachandra has been reappointed as the company's chief scientific officer, effective Friday. Ramachandra left Hospira this... -
Hospira sues competitor over pump patent infringement
Bloomberg News reports: Hospira has sued the U.S. unit of a German competitor or medical patents. In the suit, Hospira charges B. Braun Medical with making and selling drug-delivery systems without its permission. Get the full story: bloomberg.com
Tags: B. Braun Medical Inc., Patents, Copyrights and Trademarks
-
The day ahead in business May 8
Reports: MBA mortgage index for week ended May 4, 6:30 a.m.; Crude inventories for week ended May 4, 9:30 a.m. Local earnings: CF Industries Holdings Inc., Groupon Inc., Manitex International Inc., Middleby Corp., MYR Group Inc., Nanosphere Inc.,...
Tags: Cosi Incorporated, iPass Incorporated, Deutsche Telekom AG, Steinway & Sons, AOL LLC
-
U.S. RESEARCH ROUNDUP: MasterCard, Visa, Facebook, Las Vegas Sands
ReutersMay 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Visa and Facebook, on Thursday. HIGHLIGHTS * MasterCard Inc : Nomura cuts target price to $593 from $611; rating buy * DXP...Tags: JDS Uniphase Corporation, Cigna Corporation, Automotive Equipment, Newmont Mining Corporation, Pinnacle Entertainment Incorporated
-
Hospira phasing out troubled infusion pumps
Tribune staff reporterHospira Inc. on Wednesday said it will phase out a handful of its drug infusion pumps after receiving a notice from the Food and Drug Administration questioning the quality of those devices. The Lake Forest-based maker of injectable drugs and infusion...Tags: Food and Drug Administration, Companies and Corporations, Thomson Corporation, Economy, Business and Finance, Earnings
-
Hospira to eliminate Symbiq, other drug pumps after FDA scrutiny
Hospira Inc. on Wednesday said it will phase out a handful of its drug infusion pumps as part of a streamlining effort spurred in part by continued scrutiny from the Food and Drug Administration about quality issues. The Lake Forest-based maker of...
Tags: Food and Drug Administration, Marketing, Companies and Corporations, Thomson Corporation, Economy, Business and Finance
-
The day ahead in business May 1
Reports: MBA mortgage index for week ended April 27, 6 a.m.; ADP employment change for April, 7:15 a.m.; PMI manufacturing index for April, 7:58 a.m.; ISM manufacturing index for April, 9 a.m.; Construction spending for March, 9 a.m.; Crude inventories...
Tags: Allstate Corp., Tellabs Incorporated, Hyatt Hotels Corp., Las Vegas Sands Corporation, Energizer Holdings Incorporated
Feb 21, 2012
|Story| AP Broadcast
Jan 21, 2011
|Story| AP Broadcast
May 20, 2013
|Story| Reuters
May 20, 2013
|Story| Reuters
May 16, 2013
|Story| Chicago Tribune
May 14, 2013
|Story| Chicago Tribune
May 9, 2013
|Story| Chicago Tribune
May 8, 2013
|Story| Chicago Tribune
May 2, 2013
|Story| Reuters
May 1, 2013
|Story| Chicago Tribune
May 2, 2013
|Story| Chicago Tribune
May 1, 2013
|Story| Chicago Tribune
Original site for Hospira, Inc. topic gallery.
